Increased intra-tumoral SST expression may in turn lead to anti-secretory and anti-proliferative effects, whereas increased SSTR2 expression could improve tumor visibility with SSTR-scintigraphy and enhance tumor response to (radiolabeled) SSAs. The gene discussed is SSTR2; the disease is neoplasm.